1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	delivery.n	Delivery	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	drug.n	Cause_harm	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	have.v	Possession	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	role.n	Performers_and_roles	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	future.n	Temporal_collocation	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	of.prep	Age	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	_	_	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	1	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	1	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	1	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	1	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	1	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	1	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	1	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	1	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	1	_	_	_	_	_	medicine.n	Medical_specialties	O
18	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
2	review	_	review	_	NN	2	_	_	_	_	_	_	_	O
3	covets	_	UNK	_	VBZ	2	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
5	principles	_	principle	_	NNS	2	_	_	_	_	_	_	_	O
6	,	_	,	_	,	2	_	_	_	_	_	_	_	O
7	advantages	_	advantage	_	NNS	2	_	_	_	_	_	_	_	O
8	,	_	,	_	,	2	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
10	drawbacks	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	O
12	passive	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
14	active	_	active	_	JJ	2	_	_	_	_	_	_	_	O
15	targeting	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
16	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
18	various	_	various	_	JJ	2	_	_	_	_	_	_	_	O
19	polymer	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
21	magnetic	_	magnetic	_	JJ	2	_	_	_	_	_	_	_	O
22	iron	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
23	oxide	_	oxide	_	NN	2	_	_	_	_	_	_	_	O
24	nanoparticle	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
25	carriers	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	2	_	_	_	_	_	_	_	O
27	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	O
28	attached	_	attach	_	VBN	2	_	_	_	_	_	_	_	O
29	by	_	by	_	IN	2	_	_	_	_	_	_	_	O
30	both	_	both	_	DT	2	_	_	_	_	_	_	_	O
31	covalent	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
33	noncovalent	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
34	pathways	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
35	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
2	review	_	review	_	NN	2	_	_	_	_	_	_	_	O
3	covets	_	UNK	_	VBZ	2	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
5	principles	_	principle	_	NNS	2	_	_	_	_	_	_	_	O
6	,	_	,	_	,	2	_	_	_	_	_	_	_	O
7	advantages	_	advantage	_	NNS	2	_	_	_	_	_	_	_	O
8	,	_	,	_	,	2	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
10	drawbacks	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
12	passive	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
14	active	_	active	_	JJ	2	_	_	_	_	_	active.a	Active_substance	O
15	targeting	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
16	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
18	various	_	various	_	JJ	2	_	_	_	_	_	_	_	O
19	polymer	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
21	magnetic	_	magnetic	_	JJ	2	_	_	_	_	_	_	_	O
22	iron	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
23	oxide	_	oxide	_	NN	2	_	_	_	_	_	_	_	O
24	nanoparticle	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
25	carriers	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	2	_	_	_	_	_	_	_	O
27	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	O
28	attached	_	attach	_	VBN	2	_	_	_	_	_	_	_	O
29	by	_	by	_	IN	2	_	_	_	_	_	_	_	O
30	both	_	both	_	DT	2	_	_	_	_	_	_	_	O
31	covalent	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
33	noncovalent	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
34	pathways	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
35	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
2	review	_	review	_	NN	2	_	_	_	_	_	_	_	O
3	covets	_	UNK	_	VBZ	2	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
5	principles	_	principle	_	NNS	2	_	_	_	_	_	_	_	O
6	,	_	,	_	,	2	_	_	_	_	_	_	_	O
7	advantages	_	advantage	_	NNS	2	_	_	_	_	_	_	_	O
8	,	_	,	_	,	2	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
10	drawbacks	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
12	passive	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
14	active	_	active	_	JJ	2	_	_	_	_	_	_	_	O
15	targeting	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
16	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	2	_	_	_	_	_	_	_	O
18	various	_	various	_	JJ	2	_	_	_	_	_	_	_	O
19	polymer	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
21	magnetic	_	magnetic	_	JJ	2	_	_	_	_	_	_	_	O
22	iron	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
23	oxide	_	oxide	_	NN	2	_	_	_	_	_	_	_	O
24	nanoparticle	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
25	carriers	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	2	_	_	_	_	_	_	_	O
27	drug	_	drug	_	NN	2	_	_	_	_	_	drug.n	Cause_harm	O
28	attached	_	attach	_	VBN	2	_	_	_	_	_	_	_	O
29	by	_	by	_	IN	2	_	_	_	_	_	_	_	O
30	both	_	both	_	DT	2	_	_	_	_	_	_	_	O
31	covalent	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	2	_	_	_	_	_	_	_	O
33	noncovalent	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
34	pathways	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
35	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	attention	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	3	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
5	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	3	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
9	targeting	_	target	_	VBG	3	_	_	_	_	_	_	_	O
10	ligands	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	e.g.	_	e.g.	_	NN	3	_	_	_	_	_	_	_	O
13	,	_	,	_	,	3	_	_	_	_	_	_	_	O
14	enzymes	_	UNK	_	RB	3	_	_	_	_	_	_	_	O
15	,	_	,	_	,	3	_	_	_	_	_	_	_	O
16	antibodies	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	,	_	,	_	,	3	_	_	_	_	_	_	_	O
18	peptides	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	)	_	)	_	)	3	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
21	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
22	carrier	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	systems	_	system	_	NNS	3	_	_	_	_	_	_	_	O
24	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	attention	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	3	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	3	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	O
9	targeting	_	target	_	VBG	3	_	_	_	_	_	_	_	O
10	ligands	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	e.g.	_	e.g.	_	NN	3	_	_	_	_	_	_	_	O
13	,	_	,	_	,	3	_	_	_	_	_	_	_	O
14	enzymes	_	UNK	_	RB	3	_	_	_	_	_	_	_	O
15	,	_	,	_	,	3	_	_	_	_	_	_	_	O
16	antibodies	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	,	_	,	_	,	3	_	_	_	_	_	_	_	O
18	peptides	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	)	_	)	_	)	3	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
21	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
22	carrier	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	systems	_	system	_	NNS	3	_	_	_	_	_	_	_	O
24	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	attention	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	3	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	3	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
9	targeting	_	target	_	VBG	3	_	_	_	_	_	target.v	Aiming	O
10	ligands	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	e.g.	_	e.g.	_	NN	3	_	_	_	_	_	_	_	O
13	,	_	,	_	,	3	_	_	_	_	_	_	_	O
14	enzymes	_	UNK	_	RB	3	_	_	_	_	_	_	_	O
15	,	_	,	_	,	3	_	_	_	_	_	_	_	O
16	antibodies	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	,	_	,	_	,	3	_	_	_	_	_	_	_	O
18	peptides	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	)	_	)	_	)	3	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
21	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
22	carrier	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	systems	_	system	_	NNS	3	_	_	_	_	_	_	_	O
24	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	attention	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	3	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	3	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
9	targeting	_	target	_	VBG	3	_	_	_	_	_	_	_	O
10	ligands	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	e.g.	_	e.g.	_	NN	3	_	_	_	_	_	_	_	O
13	,	_	,	_	,	3	_	_	_	_	_	_	_	O
14	enzymes	_	UNK	_	RB	3	_	_	_	_	_	_	_	O
15	,	_	,	_	,	3	_	_	_	_	_	_	_	O
16	antibodies	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	,	_	,	_	,	3	_	_	_	_	_	_	_	O
18	peptides	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	)	_	)	_	)	3	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
21	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	O
22	carrier	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	systems	_	system	_	NNS	3	_	_	_	_	_	_	_	O
24	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	similarly	_	UNK	_	RB	4	_	_	_	_	_	_	_	O
2	,	_	,	_	,	4	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	4	_	_	_	_	_	approach.n	Means	O
5	toward	_	toward	_	IN	4	_	_	_	_	_	_	_	O
6	controlled	_	control	_	VBN	4	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	O
8	release	_	release	_	NN	4	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	4	_	_	_	_	_	_	_	O
10	discussed	_	discuss	_	VBN	4	_	_	_	_	_	_	_	O
11	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	similarly	_	UNK	_	RB	4	_	_	_	_	_	_	_	O
2	,	_	,	_	,	4	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	4	_	_	_	_	_	_	_	O
5	toward	_	toward	_	IN	4	_	_	_	_	_	_	_	O
6	controlled	_	control	_	VBN	4	_	_	_	_	_	control.v	Being_in_control	O
7	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	O
8	release	_	release	_	NN	4	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	4	_	_	_	_	_	_	_	O
10	discussed	_	discuss	_	VBN	4	_	_	_	_	_	_	_	O
11	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	example.n	Instance	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	_	_	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	_	_	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	_	_	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	respect.n	Judgment	O
35	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	_	_	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	_	_	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	_	_	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	5	_	_	_	_	_	to.prep	Goal	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	_	_	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	_	_	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	_	_	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	distribution.n	Dispersal	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	_	_	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	_	_	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	_	_	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	scheme.n	Project	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	5	_	_	_	_	_	_	_	O
5	,	_	,	_	,	5	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	5	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	5	_	_	_	_	_	_	_	O
8	,	_	,	_	,	5	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
12	(	_	(	_	(	5	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
14	)	_	)	_	)	5	_	_	_	_	_	_	_	O
15	,	_	,	_	,	5	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
17	(	_	(	_	(	5	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
19	)	_	)	_	)	5	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
21	(	_	(	_	(	5	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
23	)	_	)	_	)	5	_	_	_	_	_	_	_	O
24	,	_	,	_	,	5	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	5	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
27	,	_	,	_	,	5	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	5	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	5	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	5	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
37	,	_	,	_	,	5	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	5	_	_	_	_	_	_	_	O
39	,	_	,	_	,	5	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
41	,	_	,	_	,	5	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
44	(	_	(	_	(	5	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	5	_	_	_	_	_	_	_	O
47	)	_	)	_	)	5	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	5	_	_	_	_	_	of.prep	Age	O
49	administrated	_	UNK	_	VBN	5	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	O
51	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	_	_	O
19	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	cluster.n	Aggregate	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	_	_	O
19	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	accord.v	Be_in_agreement_on_action	O
19	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	_	_	O
19	to	_	to	_	TO	6	_	_	_	_	_	to.prep	Goal	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	_	_	O
19	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
3	structure	_	structure	_	NN	6	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
5	superparamagnetic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
6	iron	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
7	oxide	_	oxide	_	NN	6	_	_	_	_	_	_	_	O
8	nanoparticles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
9	(	_	(	_	(	6	_	_	_	_	_	_	_	O
10	spion	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
11	)	_	)	_	)	6	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
13	condensed	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
14	magnetic	_	magnetic	_	JJ	6	_	_	_	_	_	_	_	O
15	clusters	_	cluster	_	NNS	6	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
17	classified	_	classify	_	VBN	6	_	_	_	_	_	_	_	O
18	according	_	accord	_	VBG	6	_	_	_	_	_	_	_	O
19	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
21	mechanism	_	mechanism	_	NN	6	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	6	_	_	_	_	_	load.v	Placing	O
26	involving	_	involve	_	VBG	6	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	,	_	,	_	,	6	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	6	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
34	,	_	,	_	,	6	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	principles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
3	covalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	conjugation	_	conjugation	_	NN	7	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
6	drugs	_	drug	_	NNS	7	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
9	including	_	include	_	VBG	7	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
13	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
14	,	_	,	_	,	7	_	_	_	_	_	_	_	O
15	amide	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
16	linkage	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
17	,	_	,	_	,	7	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
19	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
20	,	_	,	_	,	7	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
23	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
24	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
25	also	_	also	_	RB	7	_	_	_	_	_	_	_	O
26	thoroughly	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
27	described	_	describe	_	VBN	7	_	_	_	_	_	_	_	O
28	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	principles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
3	covalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	conjugation	_	conjugation	_	NN	7	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
6	drugs	_	drug	_	NNS	7	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
9	including	_	include	_	VBG	7	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
13	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
14	,	_	,	_	,	7	_	_	_	_	_	_	_	O
15	amide	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
16	linkage	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
17	,	_	,	_	,	7	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
19	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
20	,	_	,	_	,	7	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
23	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
24	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
25	also	_	also	_	RB	7	_	_	_	_	_	_	_	O
26	thoroughly	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
27	described	_	describe	_	VBN	7	_	_	_	_	_	_	_	O
28	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	principles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
3	covalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	conjugation	_	conjugation	_	NN	7	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
6	drugs	_	drug	_	NNS	7	_	_	_	_	_	drug.n	Cause_harm	O
7	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
9	including	_	include	_	VBG	7	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
13	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
14	,	_	,	_	,	7	_	_	_	_	_	_	_	O
15	amide	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
16	linkage	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
17	,	_	,	_	,	7	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
19	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
20	,	_	,	_	,	7	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
23	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
24	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
25	also	_	also	_	RB	7	_	_	_	_	_	_	_	O
26	thoroughly	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
27	described	_	describe	_	VBN	7	_	_	_	_	_	_	_	O
28	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	principles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
3	covalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	conjugation	_	conjugation	_	NN	7	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
6	drugs	_	drug	_	NNS	7	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	7	_	_	_	_	_	with.prep	Accompaniment	O
8	unk	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
9	including	_	include	_	VBG	7	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
13	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
14	,	_	,	_	,	7	_	_	_	_	_	_	_	O
15	amide	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
16	linkage	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
17	,	_	,	_	,	7	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
19	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
20	,	_	,	_	,	7	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
23	bonds	_	bond	_	NNS	7	_	_	_	_	_	_	_	O
24	are	_	be	_	VBP	7	_	_	_	_	_	_	_	O
25	also	_	also	_	RB	7	_	_	_	_	_	_	_	O
26	thoroughly	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
27	described	_	describe	_	VBN	7	_	_	_	_	_	_	_	O
28	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	finally.adv	Time_vector	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	result.n	Earnings_and_losses	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	trial.n	Operational_testing	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	potential.a	Capability	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	future.a	Temporal_collocation	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	8	_	_	_	_	_	_	_	O
2	,	_	,	_	,	8	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	8	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	8	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	8	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	8	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	8	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	8	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	8	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	8	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	8	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	8	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	8	_	_	_	_	_	therapy.n	Cure	O
26	.	_	.	_	.	8	_	_	_	_	_	_	_	O

